Esta traducción se está preparando. Mientras tanto, mostramos temporalmente la versión original en inglés.
Negocios · 22/6/20041 min de lectura
Guidances for Industry on Medical Imaging Drug and Biological Products; Availability
Traducción automática local · Idioma original de la fuente
Resumen
The Food and Drug Administration (FDA) is announcing the availability of three guidances for industry on "Developing Medical Imaging Drug and Biological Products." These guidances are intended to assist developers of medical imaging drug and biological products (medical imaging agents) in planning and coordinating their clinical investigations and preparing and submitting investigational new drug applications (INDs), new drug applications (NDAs), biologics license applications (BLAs), abbreviated new drug applications (ANDAs), and supplements to NDAs or BLAs.
Idioma original de la fuente: Federal Register — Food and Drug AdministrationAbrir el comunicado original →